Functional Status Enhances the FRAX® Prediction of Fractures in Myasthenia Gravis: A 10-Year Cohort Study

<b>Background</b>: Patients with myasthenia gravis (MG) are susceptible to fractures due to glucocorticoid (GC) use and disease-related functional impairment affecting activities of daily living (ADL). The Fracture Risk Assessment Tool (FRAX<sup>®</sup>) estimates fracture probability but does not incorporate disease-specific functional status. We investigated whether combining FRAX<sup>®</sup> with the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale improves fracture risk stratification in MG patients. <b>Methods</b>: This single-center prospective cohort study followed 53 MG patients for 10 years (2012-2022) at Toho University Ohashi Medical Center, Japan. Patients were categorized into four groups based on baseline FRAX<sup>®</sup> probability (calculated with bone mineral density [BMD]) and MG-ADL scores using median splits: high FRAX<sup>®</sup>/high MG-ADL (HH), high FRAX<sup>®</sup>/low MG-ADL (HL), low FRAX<sup>®</sup>/high MG-ADL (LH), and low FRAX<sup>®</sup>/low MG-ADL (LL). The primary outcome was incident major osteoporotic fracture (MOF). <b>Results</b>: Over 10 years, nine MOFs occurred: seven in the HH group (43.8%), two in the HL group (16.7%), and none in the LH or LL groups. Fracture-free survival differed significantly among the groups (log-rank <i>p</i> < 0.001), with the HH group exhibiting the lowest survival rate. Baseline characteristics, including age, disease duration, MG severity scores, BMD, and FRAX<sup>®</sup> scores, differed significantly among groups. Specific MG-ADL items reflecting greater impairment (impairment of ability to arise from a chair, double vision, and ptosis) were significantly more pronounced in the HH group at baseline. <b>Conclusions</b>: Combining baseline FRAX<sup>®</sup> scores with the MG-ADL assessment effectively stratifies long-term MOF risk in patients with MG. Individuals with both high FRAX<sup>®</sup> and high MG-ADL represent a particularly high-risk subgroup. This dual-assessment approach may improve the identification of patients requiring targeted preventive interventions.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-05-07
DOI
https://doi.org/10.3390/jcm14093260
Citations
1
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Functional Status Enhances the FRAX® Prediction of Fractures in Myasthenia Gravis: A 10-Year Cohort Study

Hideo Kihara, Hideki Sugimoto, Shingo Konno, Takafumi Uchi
1 citations
Journal of Clinical Medicine
Myasthenia Gravis and Thymoma
1.39
article

Functional Status Enhances the FRAX® Prediction of Fractures in Myasthenia Gravis: A 10-Year Cohort Study

Hideo Kihara, Hideki Sugimoto, Shingo Konno, Takafumi Uchi
article en
1 citations

Abstract

<b>Background</b>: Patients with myasthenia gravis (MG) are susceptible to fractures due to glucocorticoid (GC) use and disease-related functional impairment affecting activities of daily living (ADL). The Fracture Risk Assessment Tool (FRAX<sup>®</sup>) estimates fracture probability but does not incorporate disease-specific functional status. We investigated whether combining FRAX<sup>®</sup> with the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale improves fracture risk stratification in MG patients. <b>Methods</b>: This single-center prospective cohort study followed 53 MG patients for 10 years (2012-2022) at Toho University Ohashi Medical Center, Japan. Patients were categorized into four groups based on baseline FRAX<sup>®</sup> probability (calculated with bone mineral density [BMD]) and MG-ADL scores using median splits: high FRAX<sup>®</sup>/high MG-ADL (HH), high FRAX<sup>®</sup>/low MG-ADL (HL), low FRAX<sup>®</sup>/high MG-ADL (LH), and low FRAX<sup>®</sup>/low MG-ADL (LL). The primary outcome was incident major osteoporotic fracture (MOF). <b>Results</b>: Over 10 years, nine MOFs occurred: seven in the HH group (43.8%), two in the HL group (16.7%), and none in the LH or LL groups. Fracture-free survival differed significantly among the groups (log-rank <i>p</i> < 0.001), with the HH group exhibiting the lowest survival rate. Baseline characteristics, including age, disease duration, MG severity scores, BMD, and FRAX<sup>®</sup> scores, differed significantly among groups. Specific MG-ADL items reflecting greater impairment (impairment of ability to arise from a chair, double vision, and ptosis) were significantly more pronounced in the HH group at baseline. <b>Conclusions</b>: Combining baseline FRAX<sup>®</sup> scores with the MG-ADL assessment effectively stratifies long-term MOF risk in patients with MG. Individuals with both high FRAX<sup>®</sup> and high MG-ADL represent a particularly high-risk subgroup. This dual-assessment approach may improve the identification of patients requiring targeted preventive interventions.

Journal of Clinical MedicineVol. 14(9)
Toho University (JP), Toho University Ohashi Medical Center (JP)
Good health and well-being
Openalex Percentile: Top 20%
Myasthenia Gravis and Thymoma
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.